ESGO Gynae-Oncology Guidelines – ESGO Gynaecological Oncology Guidelines

Publications

ESGO Vulvar cancer guidelines update 2023

ESGO/ESTRO/SIOPe Guidelines for the management of patients with vaginal cancer

ESGO/ESTRO/ESP Cervical cancer guidelines update 2023

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

ESGO/ESTRO Quality indicators of radiation therapy of cervical cancer

ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial cancer

ESGO Guidelines on Peri-operative Management of Advanced Ovarian Cancer Patients Undergoing Debulking Surgery

New ESGO/ISUOG/IOTA/ESGE Consensus Statement on Pre-Operative Diagnosis of Ovarian Tumours Now Released on IJGC!

ESGO Guidelines on quality indicators for the surgical treatment of endometrial carcinoma

ESGO-GCIG Rare Tumours Algorithms in Mobile APP

Launched in October 2022:

      • Ovarian Carcinoid Tumour
      • Borderline Ovarian Tumours
      • High-Grade Endometrial & Undifferentiated Uterine Sarcoma
      • Small Cell Neuroendocrine Carcinoma of the Cervix
      • Vulvar & Vaginal Rare Tumours

 

Launched in December 2020

      • Sex cord stromal tumours
      • Germ cell tumours of the ovary
      • Mucinous carcinoma of the ovary
      • Low grade serous carcinoma
      • Clear cell carcinoma of the ovary
Gynea-Cancer_App_Twitter

You can download it here:

ESGO Pocket Guidelines

Designed & Reviewed by Leading Experts to Advance Standards of Care and Practice

ESGO's Annual Congress 2023: Register Now & Save!

Then the ESGO congress is a can’t-miss event, held from September 28-October 1, 2023, in Istanbul, Türkiye.

Abstracts Submission deadline May 8, 2023

Early-bird Registration ends on July 10, 2023. Register Now and Save!

Ovarian Cancer Surgery

Quality indicators

New! 10 quality indicators for advanced ovarian cancer surgery to  improve your clinical practice.

Certification Process

Raise Standards of Care and view the certification process for ovarian cancer surgery.